ITInna A. Tulina

Inna A. Tulina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Inna A. Tulina has a total of 226 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short- and Long-term Outcomes of Three-Row Versus Two-Row Circular Staplers for Low Colorectal Anastomosis After Total Mesorectal Excision: A Single-Center, Randomized, Single-Blind, Phase III Trial (THREESTAPLER Study)

    by Inna Tulina, Petr Tsugulya, Valeriia Kim, Mingze He, Vladimir Balaban, Petr Tsarkov

    BACKGROUND: Anastomotic leakage remains a critical complication in colorectal surgery. OBJECTIVE: This study compared the efficacy of three-row versus two-row circular staplers in reducing anastomotic leakage rates. DESIGN: Prospective, randomized, single-center, non-inferiority trial. SETTINGS: Clinic of Colorectal and Minimally Invasive Surgery, University Hospital Nº 2, Sechenov University. PATIENTS: The trial included patients who underwent low anterior resection with total mesorectal excision. INTERVENTIONS: Patients were randomized 1:1 to 2-row or 3-row stapler group using centralized, computer-generated randomization. Outcome adjudicators, data collectors, and data analysts were blinded. MAIN OUTCOME MEASURES: Anastomotic leakage incidence; intra- and postoperative anastomotic bleeding; 30-day complications; low anterior resection syndrome; anastomotic stenosis; adverse events; time to and permanence of stoma; and 5-year overall survival. RESULTS: Among 154 patients included in the study, the anastomotic leakage rate was 16.9% (13/77) in the 3-row group compared to 15.6% (12/77) in the 2-row group ( p = 0.8). The observed difference between groups was 1.3%, with a one-sided 95% confidence interval bounded below by -8.47%. The rates of anastomotic stricture were 1.4% (n = 2) in the two-row group and 0.7% (n = 1) in the 3-row group ( p = 1). No patients experienced anastomotic hemorrhage. Stoma closure was successfully performed in 147 patients (95.5%). The 5-year overall survival was 80.2% (95% confidence interval, 69.4-92.8) in the 3-row group versus 83.8% (95% confidence interval, 75.6-92.3) in the 2-row group ( p = 0.80). LIMITATIONS: Routine postoperative proctography was not performed, clinically silent (Grade A) leaks may have been missed; the study was underpowered because the assumed 12% anastomotic leakage difference for sample-size estimation was optimistic; neoadjuvant regimen heterogeneity may have influenced outcomes; and the single-center design may limit generalizability. CONCLUSIONS: The three-row stapler was not non-inferior to the 2-row stapler in preventing anastomotic leakage. See Video Abstract . Clinical trial registration number: NCT03910699


  • Open Access

    A Case Series of Prostate Cancer Metastases to the Sigmoid Mesocolon in Patients with Colorectal Cancer

    by A. V. Nikishina, I. S. Ignatov, V. V. Balaban, N. V. Kretova, I. A. Tulina, A. N. Stetsyuk, Yu. V. Lerner, P. V. Tsarkov

    This article presents three rare clinical cases of prostate cancer metastasis to the mesosigmoid lymph nodes in patients with primary multiple prostate and sigmoid colon cancer. We were able to find descriptions of only three similar cases in international literature. In all cases, the source of metastasis was confirmed by immunohistochemistry: expression of prostate biomarkers and the absence of expression of intestinal adenocarcinoma markers were detected. Furthermore, we describe a case of the so-called “collision phenomenon” in one of the lymph nodes. The detection of prostate cancer metastases to the mesocolic region demonstrates the interconnection between the lymphatic collectors of the colon and the prostate gland. Therefore, it is important to conduct a thorough pathological examination of the surgical specimen, and in ambiguous cases, immunohistochemistry is indicated for accurate diagnosis and treatment planning. Further studies are needed to investigate the relationship between lymphatic drainage pathways from the prostate and distal colon.

  • Open Access

    Comparison of short-term outcomes of D2 and D3 lymph nodes dissection for colon cancer

    by V. V. Balaban, M. G. Mutyk, N. V. Bondarenko, S. E. Zolotukhin, O. V. Sovpel, I. V. Sovpel, M. M. Klochkov, D. S. Zykov, I. V. Rublevskyi, I. A. Tulina, et al.

    Background. D3 lymph node dissection remains controversial in colon cancer surgery.Aim. To compare the short-term of D2 and D3 lymph nodes dissection for colon cancer.Materials and methods. Design of the study – prospective randomize controlled study. Inclusion criteria: age over 18 years, colon adenocarcinoma cT3–4n0–2m0, patient consent to participate in the study. Exclusion criteria: distant metastases diagnosed preoperatively, cTis–T2, cT4b (pancreas, stomach, small intestine, ureter, bladder, kidney), emergent cases (limited to tumor perforation, acute bowel obstruction), history of previous chemotherapy or radiation therapy, synchronous or metachronous cancer, pregnancy or breastfeeding, refusal to participate in the study. withdrawal criteria were exploratory laparotomy/laparoscopy or other reasons for refusing resection.Results. A total of 436 patients were included in the study no differences were found in the clinical characteristics of groups D2 and D3. In the D2 lymph node dissection group the incidence of unintentional vascular injuries was in 7 (3.2 %) patients, in the D3 lymph node dissection group – in 15 (6.9 %) patients (p = 0.12). The operating time increased by 30 minutes in D3 lymph node dissection group (p p = 0.42). Hartmann’s procedure was performed in 2 (0.9 %) patients in the D2 lymph node dissection group. Complications IIIb were recorded in 5 (2.3 %) and 9 (4.1 %) patients in lymph node dissection groups D2 and D3, respectively (p = 0.42). Anastomotic leakage was not observed in the D2 lymph node dissection group; in the D3 lymph node dissection group, it was diagnosed in 3 (1.4 %) patients (p = 0.25). postoperative multiple-organ failure (Iv) or mortality (v) were not observed. grade 3 quality of the specimen was observed in 160 (73.4 %) patients in the D2 lymph node dissection group, 163 (74.8 %) in the D3 lymph node dissection group (p = 0.79). The median number of lymph node harvested was 11 more in the D3 lymph node dissection group (p 0.001). Apical lymph nodes were positive in 5 (2.3 %) patients in the D3 lymph node dissection group. There was no difference between the groups in R0 resection margin.Conclusion. D3 lymph node dissection is safe in terms of short-term outcomes in the treatment of colon cancer.


  • Randomized non-inferiority single-center prospective trial of malignant colonic obstruction therapy with Self-expandable metal stent (SEMS) endoscopic placement or stoma formation

    by I.E. Gorovaia, P.V. Tsarkov, P.V. Pavlov, I.A. Tulina, V.I. Zhurkovskiy

    Malignant colonic obstruction (MCO) is a pathological condition in which there is a complete or partial cessation of the passage through the intestinal tube. The emergency nature of the MCO leads to the need for decompression of proximal intestinal in the shortest possible time, especially in patients with severe concomitant diseases. The purpose of the study is to compare the effectiveness of bowel preparation for surgical treatment in patients with colorectal cancer complicated by MCO with the use of endoscopic stenting and the unloading stoma formation. This work is a prospective, single-center, randomized study. All consecutively admitted to the Clinic of Colorectal and Minimally Invasive Surgery, The Second University Clinic patients with colorectal cancer complicated by MCO were included. All patients, included in the study, were randomized into two groups: group I — patients who underwent endoscopic placement of a self-expanding metal stent to resolve MCO, group II — unloading intestinal stoma formation. The proposed study design allows us to obtain data of the efficacy and safety of the compared methods for the resolution of MCO. The use of a randomized approach improves the level of evidence. Wider acceptance, in turn, will allow designing a multicenter randomized trial to provide a large sample of patients and a definitive answer to the question of the role of endoscopic stenting as a clinical recommendation for the resolution of MCO in colorectal cancer. Despite all efforts aimed at early diagnosis of colorectal cancer, tumors usually remain undiagnosed on the early stages due to their asymptomatic form. Frequently, patients find out about their diagnosis when treatment of CRC complications, such as bleeding or MCO, begins. It has been shown that in order to improve oncological and functional results, it is necessary to resolve MCO firstly. Classically, surgeons performs stoma formation for this purpose, however the use of endoscopic stents is still a matter of debate. This is also due to the lack of a sufficient number of studies with a high level of evidence.

  • Efficacy of Micronized Purified Flavonoid Fraction in the Posthemorrhoidectomy Period Trial: Open-Label Randomized Controlled Trial

    by Yuliya Sergeevna Medkova, Inna M.D. Tulina, Valeriya Yudina, Ruslan Abdullaev, Vlada Shcherbakova, Ivan M.D. Novikov, Andrey M.D. Nikonov, Petr M.D. Tsarkov, Scherbakova Vlada

    BACKGROUND: Frequent early postoperative complications of hemorrhoidectomy are thrombosis and edema of mucocutaneous “bridges.” OBJECTIVE: This study aimed to investigate the efficacy of micronized purified flavonoid fraction in preventing complications after elective hemorrhoidectomy. DESIGN: Prospective unicentral open-label randomized controlled trial. SETTINGS: 2021–2022 at the Clinic of Colorectal and Minimally Invasive Surgery at Sechenov University (Moscow, Russia). PATIENTS: Patients who underwent hemorrhoidectomy for grade III and IV hemorrhoids. INTERVENTIONS: After hemorrhoidectomy, patients were randomly assigned either to standard treatment (peroral nonsteroid anti-inflammatory drugs and local anesthetics, topical steroids, psyllium, warm sitz baths, and nifedipine gel), referred to as the control group, or to standard treatment with micronized purified flavonoid fraction, referred to as the study group, and followed up for 60 days. MAIN OUTCOME MEASURES: Thrombosis or edema of mucocutaneous bridges and pain intensity on a visual analog scale оn postoperative days 1-7, 14, 21, and 30; quality of life and patient-assessed treatment effect оn postoperative days 1, 3, 7, 21, and 30; and perianal skin tags оn postoperative day 60. RESULTS: The data from 50 patients were analyzed (25 in each group). The visual analog scale demonstrated no differences between groups in each follow-up point. Compared to the control group, the patients in the study group had a significantly higher patient-assessed treatment effect оn postoperative days 1, 3, 7, 21, and 30 and a significantly lower rate of thrombosis or edema of mucocutaneous bridges оn postoperative days 1-7 and 14. Patients in the study group had significantly lower rates of perianal skin tags. LIMITATIONS: Unicenter open-label design. CONCLUSIONS: Micronized purified flavonoid fraction in the posthemorrhoidectomy period is an effective adjunct to standard treatment that helps reduce the rate of thrombosis and edema of mucocutaneous bridges, improves patient-assessed treatment effect, and prevents postoperative perianal skin tags formation. Micronized purified flavonoid fraction in the posthemorrhoidectomy period is not associated with additional pain relief in comparison with nonmicronized purified flavonoid fraction standard treatment. See Video Abstract. EFICACIA DE LA FRACCIÓN DE FLAVONOIDES PURIFICADA MICRONIZADA EN EL PERÍODO POSTERIOR A LA HEMORROIDECTOMÍA (ENSAYO MOST): ENSAYO CONTROLADO, ALEATORIZADO, ABIERTO: ANTECEDENTES: Una complicación postoperatoria temprana frecuente de la hemorroidectomía es la trombosis y el edema de los “puentes” mucocutáneos. OBJETIVO: Investigamos la eficacia de la fracción de flavonoides purificada micronizada en la prevención de complicaciones después de una hemorroidectomía electiva. DISEÑO: Ensayo controlado aleatorio, prospectivo, unicentral, abierto. AJUSTES: 2021-2022 Clínica de Cirugía Colorrectal y Mínimamente Invasiva Universidad Sechenov (Moscú, Rusia). PACIENTES: Pacientes después de hemorroidectomía, que se realizó para hemorroides de grado III-IV. INTERVENCIONES: Después de la hemorroidectomía, los pacientes fueron asignados aleatoriamente al tratamiento estándar (antiinflamatorios no esteroides perorales y anestésicos locales, esteroides tópicos, psyllium, baños de asiento tibios, gel de nifedipina) – grupo de control, o al tratamiento estándar con flavonoide purificado micronizado. fracción (grupo de estudio) y seguido durante 60 días. RESULTADOS DE MEDIDAS PRINCIPALES: Trombosis o edema de puentes mucocutáneos e intensidad del dolor en una escala analógica visual entre el 1.º, 7.º, 14.º, 21.º y 30.º día postoperatorio; calidad de vida y efecto del tratamiento evaluado por el paciente el día 1, 3, 7, 21 y 30 del postoperatorio; Marcas cutáneas perianales en el día 60 del postoperatorio. RESULTADOS: Se analizaron los datos de 50 pacientes (25 en cada grupo). La escala analógica visual no demostró diferencias entre grupos en cada punto de seguimiento. En comparación con el grupo de control, los pacientes en el grupo de estudio tuvieron un efecto del tratamiento evaluado por el paciente significativamente mayor en los días 1, 3, 7, 21 y 30 después de la operación, una tasa significativamente menor de trombosis o edema de los puentes mucocutáneos en los días 1, 7 y 14.. Los pacientes del grupo de estudio tuvieron tasas significativamente más bajas de marcas en la piel perianal. LIMITACIONES: Diseño Unicenter de etiqueta abierta. CONCLUSIONES: La fracción de flavonoides purificada micronizada en el período posterior a la hemorroidectomía es un complemento eficaz del tratamiento estándar que ayuda a reducir la tasa de trombosis y edema de los puentes mucocutáneos, mejora el efecto del tratamiento evaluado por el paciente y previene la formación de marcas cutáneas perianales posoperatorias. La fracción de flavonoides purificados micronizados en el período posterior a la hemorroidectomía no se asocia con un alivio adicional del dolor en comparación con el tratamiento estándar con la fracción de flavonoides purificados no micronizados. (Traducción—Yesenia Rojas-Khalil)


  • Open Access

    Diagnostic Interval for Oldest-Old Patients with II–III Stage Right Colon Cancer

    by P. V. Tsarkov, В. М. Нековаль, I. A. Tulina, V. V. Balaban

    Introduction: the lack of comprehensive screening programs for colorectal cancer detection in oldest-old steadily leads to an increase in the diagnostic interval (DI), i.e. the time from the patient’s first presentation of complaints until diagnosis and treatment. At the same time, worsening the general somatic condition and developing the decompensation of concomitant diseases. Thus, patients with long-term DI need additional measures while preparing for surgery; the preoperative bed-day increases.Purpose of the study: to evaluate the impact of the diagnostic interval on the short-term results of II and III stages right colon cancer treatment in geriatric patients.Materials and methods: a retrospective multicenter study was conducted at the surgical facilities of Sechenov University from 2006 to 2015. The study included patients aged over 75 who have undergone surgical treatment of II and III stages right colon cancer. The control group comprised patients with CRC diagnosis in the period from 0 to 6 months; the studied group involved patients with a diagnostic interval over than 6 months.Results and conclusions. Analysis of the results revealed that patients older than 80 years had a longer diagnostic interval, which is statistically significant (p<0.001). Prolongation of the diagnostic interval for more than 6 months has shown a decrement in the polymorbidity indicators and operational and anesthetic risk compared with DI≤6 months (p=0.001, p=0.039). Polymorbidity, in particular cardiovascular diseases decompensation, affected the indicators of operational and anesthetic risk on the ASA scale, which were significantly higher in the study group (p=0.039). High level of polymorbidity required a longer preoperative preparation in the studied group, which is statistically significant in comparison with the control group (p=0.018). Statistically significant differences in early postoperative complications rate in both groups were not revealed. 30 and 90 day mortality rates were similar in the studied and control groups (p=0.225, p=0.353). The study has also shown that diagnostic interval (DI) have no effect on the prevalence of II and III stages comparing with the control group (p=0.315).

  • Open Access

    Phlebotonics for conservative treatment of haemorrhoids: when, to whom, how?

    by D. D. Shlyk, I. A. Tulina, P. V. Tsarkov

    Hemorrhoidal disease (HD) is a pathological enlargement of the external and/or internal hemorrhoidal piles, which may be accompanied by the bleeding and prolapse of haemorrhoids outside the anal canal. The incidence of HD among the population of the Russian Federation is 130–145 patients per 1000 people, occurring mainly in patients 45–65 years old. Among all coloproctological diseases in Russia, haemorrhoids became the reason for visiting a coloproctologist in 35–41.9% of cases. In outpatient department, the disease occurs with a frequency of 694 per 100,000 population. The treatment of hemorrhoids often begins at the coloproctologist’s office during outpatient visits. Typical clinical presentations of hemorrhoids include a complex of symptoms: periodic rectal bleeding during defecation, prolapsed hemorrhoids requiring manual reduction. Pain and itching are much less common symptoms. The treatment of hemorrhoidal disease consists of a complex of conservative measures, minimally invasive and surgical treatments, or a combination of above methods. Systemic phlebotropic drugs that affect various pathogenesis links of hemorrhoidal disease hold one of the first rightful places at the very core of modern conservative therapy regimens. Phlebotropic drugs are a large group of biologically active substances that are products of chemical synthesis or plant processing. The venotonic drugs containing flavonoids diosmin and hesperidin are the most studied ones. Various effects of diosmin and hesperidin from anti-ulcerogenic and antitumor to antioxidant and anti-inflammatory ones have been studied in clinical and experimental studies. Its venotonic and angioprotective effects are the most important actions for the treatment of hemorrhoidal disease. This review of literature is aimed determining the place of phlebotonics in outpatient practice for the treatment of haemorrhoidal disease.


  • Full-wall semi-circular mobilization of posterior wall of the lower ampullar rectum for complex recurrent anorectal fistula

    by I.A. Tulina, Yu.A. Churina, Yu.S. Medkova, P.V. Tsarkov

    Objective. To describe a new technique for closure of sphincter complex defects after excision of recurrent high rectal fistulas and compare with other traditional techniques. Material and methods. We retrospectively analyzed patients operated on for recurrent posterior rectal fistula. All patients underwent fistulectomy and one of the methods for defect closure after excision of the fistula: sphincter suturing, muco-muscular flap or full-wall semicircular mobilization of the lower ampullar rectum. The last method implemented the principle of inter-sphincter resection in rectal cancer. We developed this method as an alternative to muco-muscular flap in patients with fibrosis of anal canal to form a full-thickness well-vascularized flap without tissue tension. Results. Between 2019 and 2021, 6 patients underwent fistulectomy with sphincter suturing, 5 patients — closure with muco-muscular flap, 3 males underwent full-wall semicircular mobilization of the lower ampullar rectum. There was a tendency to better continence after a year (1 (0, 1.5), 1 (0, 1.5) and 3 (1, 3) points, respectively). Postoperative follow-up period was 12.5 (10, 15), 12 (9, 15) and 16 (12, 19) months, respectively. None patient had signs of recurrence throughout the follow-up period. Conclusion. Original technique can be considered as an alternative to standard approaches in patients with high recurrent posterior anorectal fistulas, when traditional displaced endorectal flap is ineffective or impossible due to excessive scarring and anatomical changes in the anal canal.


  • Superior mesenteric artery bleeding during D3 lymph node dissection for right colon cancer–A video vignette

    by Vladimir Balaban, Inna Tulina, Petr Tsugulya, Petr Tsarkov


  • Follicular occlusion syndrome in the practice of a coloproctologist

    by Darya D. Shlyk, Yulia A. Ilyukhina, Anna S. Pirogova, Yury E. Kitsenko, Inna A. Tulina, Natalya P. Teplyuk, Petr V. Tsarkov, Илюхина Юлия Алексеевна, Киценко Юрий Евгеньевич, Теплюк Наталья Павловна

    BACKGROUND: Pilonidal disease is the 4th most common disease among inpatient coloproctological patients and surgery remains the gold standard of its treatment. However, patients with pilonidal disease often have combined conditions with other follicular occlusion diseases which are most often encountered by dermatologists in their practice. In most cases it is difficult to treat follicular occlusion syndrome with pilonidal disease within one specialty. We demonstrate the complexity of follicular occlusion diseases diagnostics in combination with pilonidal disease, systemize the diagnostic protocol for patient management and present the treatment strategy for coloproctologists. CLINICAL CASE DESCRIPTION: There was one case of patient with pilonidal disease combined with other conditions of follicular occlusion syndrome noted in the clinic of coloproctology and minimally invasive surgery. Surgery was the first step. There were no complications in the early postoperative period. After hospital discharge, the patient was consulted by a dermatologist, and local and systemic conservative therapy was prescribed for concomitant diseases, which resulted in a significant improvement. There have been no recent reports of recurrence. CONCLUSION: The treatment of follicular occlusion syndrome with pilonidal disease requires a multidisciplinary approach. At the same time the optimal treatment for pilonidal disease is radical excision of all altered tissues. In cases of such diseases as hidradenitis suppurativa, acne conglobata, dissecting cellulitis of the scalp treatment should be comprehensive and begin with a dermatologist consultation.